FY2025 · ended Dec 31, 2025 · Revenue $108.04M, -8.3% YoY · Filed Apr 15, 2026
Mannatech Inc (MTEX) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $108.0 million and a net loss of $15.2 million. Free cash flow was -$4.3 million. As of Jun 30, 2026 it held $6.0 million in cash and investments and $6.3 million in total debt.
Revenue
$108.04M
-8.3% vs prior year
Net income
$-15.21M
-711.0% vs prior year
Operating cash flow
$-2.96M
-231.0% vs prior year
Free cash flow
$-4.32M
-319.8% vs prior year
EPS
$-8.00
-706.1% vs prior year
Dividend per share
$0.20
Shares outstanding
1.93M
+1.5% vs prior year
Net cash
$-311,000
as of Jun 30, 2026
Operating margin
-0.4%
FY 2025
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- MTEX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Flower Mound, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1056358
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $108.0M | $117.9M | $132.0M | $137.2M | $159.8M |
| Operating income | -$426,000 | $1.4M | -$964,000 | -$405,000 | $9.0M |
| Net income | -$15.2M | $2.5M | -$2.2M | -$4.5M | $9.8M |
| Diluted EPS | -$8.00 | $1.32 | -$1.20 | -$2.35 | $4.71 |
| Operating cash flow | -$3.0M | $2.3M | -$2.4M | -$2.6M | $10.8M |
| Free cash flow | -$4.3M | $2.0M | -$3.1M | -$3.7M | $10.1M |
| Total assets | $30.0M | $36.1M | $41.2M | $49.1M | $59.6M |
| Total liabilities | $35.2M | $27.4M | $30.7M | $35.0M | $35.2M |
| Stockholders' equity | -$5.2M | $8.6M | $10.5M | $14.2M | $24.4M |
| Cash and investments | $6.2M | $11.4M | $7.7M | $13.8M | $24.2M |
| Total debt | $7.4M | $6.7M | $5.5M | $5.9M | $5.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K/A |
Amended current report
Auditor change
|
Oct 23, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Auditor change
|
Oct 21, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Other events
|
Oct 14, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 1, 2026 | Aug 26, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
All 1000 Mannatech Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.